Tag: Cancer: Breast
Digital Breast Tomosynthesis Can Reduce Benign Biopsy Rate
Fewer benign biopsies necessary with DBT compared with full-field digital mammography
Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone
Parity, Risk for Breast Cancer Studied for BRCA1/2 Carriers
Higher risk seen in uniparous BRCA1 carriers, parous BRCA2 carriers; breastfeeding cuts risk in BRCA1
Acupressure Reduces Lasting Symptoms in Breast Cancer Survivors
Tied to improvements in pain, anxiety, depression among breast cancer survivors with fatigue
FDA Approves First Immunotherapy Drug for Breast Cancer
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Genetic Testing Recommended for All Patients With Breast Cancer
All with personal history of breast cancer should be offered testing; updated testing recommended
Recall Down, Cancer Detection Up With Digital Breast Tomosynthesis
Breast cancers detected by DBT less often classified as having poor prognosis than those identified by DM
Breast Cancer Diagnosis Delays Seen With High-Deductible Health Plans
Delays observed in first breast imaging, biopsy, incident early-stage breast cancer diagnosis, chemo
Performance Improvement Sustained After DBT Adoption
Early improvement after adoption of digital breast tomosynthesis seen regardless of DBT volume
Robotically Assisted Devices Not Approved for Cancer Surgery
FDA aware that surgeons have been using the devices for uses not granted marketing authorization
